Results 211 to 220 of about 85,427 (313)

Vaccine Name Framing, Relationship Status, and Fear: Examining Heterosexual Men's Intention to Vaccinate Against Human Papillomavirus Infection

World Medical &Health Policy, Volume 18, Issue 1, March 2026.
ABSTRACT Against the backdrop of calling for nonfemale‐oriented promotion of vaccination against human papillomavirus (HPV), this study explored three potential names—“HPV Vaccine,” “Cervical Cancer Vaccine,” and “Genital Warts Vaccine”—to promote vaccination against HPV infection among heterosexual men.
Timothy K. F. Fung, Judy Yuen‐man Siu, Ho Man Leung   +2 more
wiley   +1 more source

Corrigendum: Risk of primary Sjogren's Syndrome following human papillomavirus infections: a nationwide population-based cohort study. [PDF]

Front Immunol
Chen HH, Ma KS, Dong C, Chang WJ, Gao KR, Perng WT, Huang JY, Wei JC.   +7 more
europepmc   +1 more source

Effects of Th17 cells and IL‐17 in the progression of cervical carcinogenesis with high‐risk human papillomavirus infection [PDF]

, 2017
Jisen Xue, Yuli Wang, Cheng Chen, Xuejie Zhu, Zhu Hua, Yan Hu   +5 more
openalex   +1 more source

Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey

International Journal of Cancer, Volume 158, Issue 4, Page 909-923, 15 February 2026.
What's new? This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...
Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang   +17 more
wiley   +1 more source

Reviewer #2 (Public review): A rapid transfer of virions coated with heparan sulfate from the ECM to CD151 defines an early step in the human papillomavirus infection cascade

Annika Massenberg, Yahya Homsi, Carl Niklas Schneider, Snježana Mikuličić, Tatjana Döring, Luise Florin, Thorsten Lang   +6 more
openalex   +1 more source

Epidemiological approaches to evaluate clinical unmasking of HPV‐associated cervical lesions in the HPV vaccination era

International Journal of Cancer, Volume 158, Issue 4, Page 847-857, 15 February 2026.
Abstract HPV vaccination reduces the risk of developing HPV‐attributable cancers, including cervical cancer. However, an attenuation of HPV vaccine impact after the implementation of HPV vaccination may occur through clinical unmasking. Clinical unmasking is a distinct and complex phenomenon that arises in the absence of clinical interventions ...
Joseph E. Tota, Jaimie Z. Shing, Jeffrey N. Roberts, Elizabeth M. Anderson, Alfred J. Saah, Ariana Harari, Eduardo L. Franco, Melvin Kohn, Susanne K. Kjær   +8 more
wiley   +1 more source

Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review. [PDF]

Genet Med
Biglari S, Moghaddam AS, Tabatabaiefar MA, Sherkat R, Youssefian L, Saeidian AH, Vahidnezhad F, Tsoi LC, Gudjonsson JE, Hakonarson H, Casanova JL, Béziat V, Jouanguy E, Vahidnezhad H.   +13 more
europepmc   +1 more source

Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytology

International Journal of Cancer, Volume 158, Issue 4, Page 931-941, 15 February 2026.
What's new? Human papillomavirus (HPV) testing has revolutionized cervical cancer screening. Nonetheless, its optimal use for distinguishing between high‐ and low‐risk infections to leverage screening benefits remains to be established. Here, long‐term HPV genotype‐specific risk of precancerous cervical intraepithelial neoplasia grade 2 or higher was ...
Maija Vahteristo, Sirpa Heinävaara, Joakim Dillner, Ilkka Kalliala, Pekka Nieminen, Tytti Sarkeala, Maarit K. Leinonen   +6 more
wiley   +1 more source

Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)‐associated tonsillar squamous cell carcinoma (TSCC)

International Journal of Cancer, Volume 158, Issue 4, Page 1080-1092, 15 February 2026.
What's new? Human papillomavirus (HPV)‐associated tonsillar squamous cell carcinoma (TSCC) is suspected of originating from tonsillar crypts, where HPV can persist in latent form. Detection is further complicated by the possible absence of premalignant stages, namely carcinoma in situ (CIS). Here, the authors investigated tumor origin in HPV‐associated
Tobias Näsman, Madeleine Birgersson, Linda Marklund, Anders Näsman   +3 more
wiley   +1 more source

Factors associated with human papillomavirus infections among women living with HIV in public health facilities in Western Oromia, Ethiopia. [PDF]

BMC Womens Health
Abdi M, Tamiru A, Tilahun T, Tiruneh G, Fite MB.   +4 more
europepmc   +1 more source